Lipoexpediency: de novo lipogenesis as a metabolic signal transmitter

被引:110
作者
Lodhi, Irfan J. [1 ]
Wei, Xiaochao [1 ]
Semenkovich, Clay F. [1 ,2 ]
机构
[1] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA
[2] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA
关键词
FATTY-ACID SYNTHASE; PROLIFERATOR-ACTIVATED RECEPTORS; CENTRAL-NERVOUS-SYSTEM; INSULIN-RESISTANCE; ADIPOSE-TISSUE; PPAR-ALPHA; ADIPOCYTE DIFFERENTIATION; ENERGY HOMEOSTASIS; HEPATIC STEATOSIS; ENDOGENOUS LIGAND;
D O I
10.1016/j.tem.2010.09.002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
De novo lipogenesis, the production of fats from simple precursors, is often dismissed as irrelevant to the pathobiology of obesity caused by positive energy balance due to typical high fat diets. However, emerging data implicate de novo lipogenesis in the generation of metabolic signals that alter disease risk. Exploiting this signaling pathway represents lipoexpediency. Lipoexpediency is the concept of directing fats toward benefit even in the setting of lipid overload, and represents a strategy to complement efforts aimed at improving energy balance. Optimizing lipid signals initiated by key lipogenic enzymes such as fatty acid synthase might limit morbidity in people who are unlikely to abandon the lifestyle of the sedentary gourmand.
引用
收藏
页码:1 / 8
页数:8
相关论文
共 69 条
[1]   Contributions of de novo synthesis of fatty acids to total VLDL-triglyceride secretion during prolonged hyperglycemia hyperinsulinemia in normal man [J].
Aarsland, A ;
Chinkes, D ;
Wolfe, RR .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 98 (09) :2008-2017
[2]   Biosynthesis of 15-deoxy-Δ12,14-PGJ2 and the litigation of PPARγ [J].
Bell-Parikh, LC ;
Ide, T ;
Lawson, JA ;
McNamara, P ;
Reilly, M ;
FitzGerald, GA .
JOURNAL OF CLINICAL INVESTIGATION, 2003, 112 (06) :945-955
[3]   Integration of metabolism and inflammation by lipid-activated nuclear receptors [J].
Bensinger, Steven J. ;
Tontonoz, Peter .
NATURE, 2008, 454 (7203) :470-477
[4]   Free fatty acids and pathogenesis of type 2 diabetes mellitus [J].
Bergman, RN ;
Ader, M .
TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2000, 11 (09) :351-356
[5]   Dexamethasone induction of hypertension and diabetes is PPAR-α dependent in LDL receptor-null mice [J].
Bernal-Mizrachi, C ;
Weng, S ;
Feng, C ;
Finck, BN ;
Knutsen, RH ;
Leone, TC ;
Coleman, TY ;
Mecham, RP ;
Kelly, DP ;
Semenkovich, CF .
NATURE MEDICINE, 2003, 9 (08) :1069-1075
[6]   As a Matter of Fat [J].
Brookheart, Rita T. ;
Michel, Carlos I. ;
Schaffer, Jean E. .
CELL METABOLISM, 2009, 10 (01) :9-12
[7]   Identification of a lipokine, a lipid hormone linking adipose tissue to systemic metabolism [J].
Cao, Haiming ;
Gerhold, Kristin ;
Mayers, Jared R. ;
Wiest, Michelle M. ;
Watkins, Steven M. ;
Hotamisligil, Goekhan S. .
CELL, 2008, 134 (06) :933-944
[8]   Brain fatty acid synthase activates PPARα to maintain energy homeostasis [J].
Chakravarthy, Manu V. ;
Zhu, Yimin ;
Lopez, Miguel ;
Yin, Li ;
Wozniak, David F. ;
Coleman, Trey ;
Hu, Zhiyuan ;
Wolfgang, Michael ;
Vidal-Puig, Antonio ;
Lane, M. Daniel ;
Semenkovich, Clay F. .
JOURNAL OF CLINICAL INVESTIGATION, 2007, 117 (09) :2539-2552
[9]   Identification of a Physiologically Relevant Endogenous Ligand for PPARα in Liver [J].
Chakravarthy, Manu V. ;
Lodhi, Irfan J. ;
Yin, Li ;
Malapaka, Raghu R. V. ;
Xu, H. Eric ;
Turk, John ;
Semenkovich, Clay F. .
CELL, 2009, 138 (03) :476-488
[10]   New hepatic fat activates PPARα to maintain glucose, lipid, and cholesterol homeostasis [J].
Chakravarthy, MV ;
Pan, ZJ ;
Zhu, YM ;
Tordjman, K ;
Schneider, JG ;
Coleman, T ;
Turk, J ;
Semenkovich, CF .
CELL METABOLISM, 2005, 1 (05) :309-322